These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4071356)

  • 21. Preleukemias.
    Nowell PC
    Hum Pathol; 1981 Jun; 12(6):522-30. PubMed ID: 7275093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Karyotype studies of patients with a myelodysplastic syndrome].
    Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
    Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytogenetic studies in hematological diseases. Analysis of 185 cases].
    Porto B; Mota A; Coutinho J; Justiça B; Malheiro MI
    Sangre (Barc); 1993 Apr; 38(2):103-14. PubMed ID: 8516724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 25. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies.
    Bacher U; Schnittger S; Grüneisen A; Haferlach T; Kern W; Haferlach C
    Cancer Genet Cytogenet; 2009 Jan; 188(2):108-11. PubMed ID: 19100515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myelodysplastic syndromes: approaches to these difficult to understand].
    Tohyama K
    Rinsho Ketsueki; 2006 Mar; 47(3):167-75. PubMed ID: 16629481
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemia.
    Shepherd L; Cameron C; Galbraith P; Windsor S; Lillicrap D
    Leuk Res; 1991; 15(5):297-303. PubMed ID: 1675299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preleukemic syndrome. II. Cytogenetic findings.
    Geraedts JP; Weber RF; Kerkhofs H; Leeksma CH
    Acta Med Scand; 1980; 207(6):447-54. PubMed ID: 7424563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
    Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monosomy 7 in hematologic processes. Clinical and prognostic implications].
    Bello López JL; Viejo Llorente A; Gómez Vázquez MJ
    Sangre (Barc); 1984; 29(3):299-301. PubMed ID: 6484779
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in myelodysplastic syndromes.
    Alfaro R; Pérez-Granero A; Durán MA; Besalduch J; Rosell J; Bernués M
    Leuk Res; 2008 Jan; 32(1):159-61. PubMed ID: 17509681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of the Ph1 chromosome in a group of chronic myeloproliferative syndromes].
    Mide de Piterbarg S; Bomchil G
    Sangre (Barc); 1969; 14(2):205-14. PubMed ID: 5804343
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hematological study in 27 patients with myelodysplastic syndrome (MDS)].
    Arai T; Taoka T; Yamaoka G; Kiuchi H; Kawanishi K
    Rinsho Byori; 1993 Jan; 41(1):107-11. PubMed ID: 8355404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.